Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 112R (IIV3-112R)

What is Recombinant Invertebrate Iridescent Virus 3 Uncharacterized Protein 112R (IIV3-112R)?

Recombinant Invertebrate Iridescent Virus 3 Uncharacterized Protein 112R (IIV3-112R) is a protein of currently unknown function derived from Invertebrate iridescent virus 3, also known as Mosquito iridescent virus. The recombinant form is typically expressed in expression systems such as E. coli with affinity tags (such as His-tag) to facilitate purification and downstream applications. The full-length protein consists of 112 amino acids, and its function remains to be fully characterized .

Unlike well-characterized proteins, IIV3-112R represents one of many uncharacterized viral proteins whose functions require structural and functional investigation. Current research approaches typically involve recombinant protein expression followed by structural and functional assays to determine its role in viral biology.

What expression systems are optimal for producing functional IIV3-112R?

For optimal expression of functional IIV3-112R, E. coli is the most commonly used system as evidenced by commercially available recombinant forms of the protein . The bacterial expression system offers advantages including:

• High yield production of the 112-amino acid protein

• Compatibility with His-tag purification systems

• Cost-effectiveness for initial characterization studies

For experimental protocols using E. coli:

• BL21(DE3) strains typically provide good expression levels

• Induction with IPTG at 0.5-1.0 mM when culture reaches OD600 of 0.6-0.8

• Expression at lower temperatures (16-25°C) may enhance solubility

• Lysis under native conditions with phosphate buffers containing imidazole

For researchers requiring potential post-translational modifications or studying protein-protein interactions, alternative expression systems to consider include:

When working with the recombinant protein, researchers should validate proper folding using circular dichroism or limited proteolysis assays regardless of the expression system used.

What experimental approaches can be used to determine the function of IIV3-112R?

Determining the function of uncharacterized proteins like IIV3-112R requires a multi-faceted approach combining computational predictions with experimental validation:

Computational approaches:

• Sequence homology analysis with known protein families

• Structure prediction using AlphaFold2 or RoseTTAFold

• Binding site prediction based on conserved motifs

• Molecular dynamics simulations to predict potential ligand interactions

The computational approach demonstrated by Konc et al. for uncharacterized proteins provides an excellent methodological framework that could be applied to IIV3-112R. Their structure-based function prediction compares predicted binding sites to libraries of candidate structures, identifying potential functional similarities .

Experimental validation approaches:

• Protein-protein interaction studies:

  • Yeast two-hybrid screening against host proteome

  • Co-immunoprecipitation followed by mass spectrometry

  • Proximity labeling (BioID/APEX) in relevant cell systems

• Functional assays:

  • Viral replication assays with and without the protein

  • Gene knockout/knockdown studies in viral context

  • Host cell response measurements (transcriptomics, proteomics)

• Biochemical characterization:

  • Enzymatic activity assays based on predicted function

  • Nucleic acid binding assays (EMSA, filter binding)

  • Structural studies (X-ray crystallography, cryo-EM)

For uncharacterized viral proteins, combining these approaches with the methodology demonstrated in the Tm1631 protein characterization case can reveal unexpected functional properties through binding site similarity assessment .

How can structure-based function prediction be applied to IIV3-112R?

Structure-based function prediction represents a powerful approach for uncharacterized proteins like IIV3-112R when sequence homology fails to identify functional relationships. The methodology can be implemented as follows:

The approach used by Konc et al. with the Tm1631 protein demonstrates the power of this method. Their comparison of predicted binding sites against a library of structures revealed similarities with nucleotide binding sites, specifically DNA-binding sites of endonuclease IV, leading to functional prediction that was then validated through modeling and molecular dynamics .

For IIV3-112R, this approach could identify unexpected functional relationships even when sequence analysis provides limited insights. Validation of computational predictions through biochemical assays remains essential for confirming function.

What are the challenges in crystallizing uncharacterized viral proteins like IIV3-112R?

Crystallizing uncharacterized viral proteins like IIV3-112R presents several unique challenges requiring specialized approaches:

Primary challenges:

• Protein stability and solubility issues:

  • Many viral proteins have evolved to function in specific host environments

  • Recombinant expression may yield improperly folded or aggregation-prone proteins

  • Solution: Screen multiple buffer conditions with thermal shift assays (DSF) to identify stabilizing conditions

• Conformational heterogeneity:

  • Viral proteins often adopt multiple conformations for function

  • Dynamic regions can hinder crystal lattice formation

  • Solution: Consider limited proteolysis to remove flexible regions or use surface entropy reduction

• Post-translational modifications:

  • Expression in bacterial systems lacks eukaryotic PTMs

  • Missing PTMs may affect folding or stability

  • Solution: Consider insect cell expression systems when bacterial expression fails

Methodological approaches:

For crystallization screening of IIV3-112R, consider:

When working with the 112-amino acid IIV3-112R protein, its relatively small size offers advantages for crystallization but may present challenges for obtaining sufficient phase information. Consider selenomethionine labeling for experimental phasing if molecular replacement isn't feasible.

How can protein-protein interaction studies be optimized for characterizing IIV3-112R?

Protein-protein interaction (PPI) studies are crucial for understanding the functional role of uncharacterized proteins like IIV3-112R. Optimizing these studies requires consideration of multiple complementary approaches:

Affinity purification-mass spectrometry (AP-MS):

• Optimized bait design:

  • Express IIV3-112R with different tags (FLAG, HA, His) to minimize tag interference

  • Include both N- and C-terminal tagged constructs to prevent blocking interaction surfaces

  • Consider native purification from viral-infected cells when possible

• Control strategies:

  • Implement SILAC or TMT labeling for quantitative comparison

  • Use tag-only controls and unrelated viral protein controls

  • Include RNase/DNase treatment to eliminate nucleic acid-mediated interactions

• Crosslinking strategies:

  • Optimize formaldehyde or DSS crosslinking to capture transient interactions

  • Consider photo-crosslinking for site-specific interaction analysis

Proximity-based approaches:

• BioID or TurboID:

  • Express IIV3-112R fused to biotin ligase in relevant host cells

  • Optimize expression levels to minimize artifacts

  • Compare proximity profiles between infected and uninfected cells

• APEX2 proximity labeling:

  • Shorter labeling window (1 minute) captures more dynamic interactions

  • Combine with subcellular fractionation to identify compartment-specific partners

Validation and functional characterization:

• Reciprocal pulldowns:

  • Confirm key interactions using reversed bait-prey configuration

  • Quantify binding affinities using surface plasmon resonance or biolayer interferometry

• Interaction mapping:

  • Create domain deletion constructs to map interaction regions

  • Use alanine scanning mutagenesis for critical residues

  • Perform competitive binding assays to identify mutually exclusive interactions

• Functional validation:

  • Assess effects of disrupting interactions on viral replication

  • Measure changes in cellular localization when interactions are disrupted

  • Determine effects on downstream signaling pathways

For uncharacterized proteins like IIV3-112R, combining multiple orthogonal interaction detection methods provides higher confidence in identifying true interacting partners versus false positives. While no specific interacting partners for IIV3-112R have been documented in the available literature , these methodological approaches provide a robust framework for characterizing its interactome.

How can contradictory experimental results about IIV3-112R function be reconciled?

When facing contradictory experimental results regarding IIV3-112R function, researchers should employ a systematic approach to identify sources of discrepancy and reconcile findings:

1. Methodological variance analysis:

• Protein preparation differences:

  • Compare expression systems used (bacterial vs. eukaryotic)

  • Analyze protein purification methods and purity assessments

  • Examine storage conditions and their impact on protein stability

• Assay condition discrepancies:

  • Create a detailed table of buffer compositions, pH, and salt concentrations

  • Compare reaction temperatures and incubation times

  • Assess differences in detection methods and their sensitivity

• Experimental design variations:

  • Analyze positive and negative controls used

  • Compare sample sizes and statistical approaches

  • Evaluate blinding and randomization protocols

2. Integrative data analysis approaches:

• Meta-analysis techniques:

  • Perform weighted analysis based on methodological rigor

  • Apply Bayesian integration of conflicting datasets

  • Use machine learning to identify patterns across contradictory results

• Orthogonal validation:

  • Design experiments that test the function through entirely different approaches

  • Validate in multiple cell lines or model systems

  • Implement CRISPR knockout studies to confirm specificity

3. Context-dependent function reconciliation:

For viral proteins like IIV3-112R, apparent contradictions may reflect genuine biological complexity:

• Host-specific effects:

  • Test function in various host cell types

  • Examine dependency on host factors that may vary between systems

• Concentration-dependent effects:

  • Perform dose-response curves at physiologically relevant concentrations

  • Consider stoichiometric relationships with interaction partners

• Temporal dynamics:

  • Investigate function at different stages of viral infection

  • Consider post-translational modifications that may vary with infection progression

4. Collaborative resolution approaches:

When contradictions persist across research groups:

• Organize inter-laboratory validation studies with standardized protocols

• Establish material sharing agreements to eliminate reagent variability

• Conduct blind parallel testing in multiple laboratories

When applying structure-based function prediction approaches as described for uncharacterized proteins , contradictions may arise between computational predictions and experimental results. In such cases, iterative refinement of structural models based on experimental feedback can help reconcile discrepancies.

What bioinformatic approaches are most valuable for predicting IIV3-112R function?

For uncharacterized proteins like IIV3-112R, bioinformatic approaches offer valuable insights into potential functions. The following methodologies provide complementary perspectives:

1. Sequence-based analyses:

• Remote homology detection:

  • Position-Specific Iterative BLAST (PSI-BLAST) to detect distant relationships

  • Hidden Markov Model profiles using HMMER

  • Profile-profile comparisons with HHpred

• Motif and domain prediction:

  • InterProScan integration of multiple domain databases

  • Conservation analysis across viral families

  • Disorder prediction to identify flexible regions

• Evolutionary analysis:

  • Phylogenetic profiling across viral species

  • Co-evolution analysis to identify functional partners

  • Selection pressure analysis (dN/dS ratios) to identify functionally important residues

2. Structure-based approaches:

• Ab initio structure prediction:

  • AlphaFold2 or RoseTTAFold modeling

  • Model quality assessment using MolProbity

• Structural similarity searches:

  • DALI or TM-align for fold recognition

  • ProBiS for binding site similarity detection

  • CASTp for pocket identification and comparison

• Molecular dynamics simulations:

  • Conformational sampling to identify functional states

  • Solvent and ion interaction analysis

  • Binding site flexibility assessment

3. Integrated prediction frameworks:

• Function prediction pipelines:

  • COFACTOR for integrated structure and sequence-based function annotation

  • DeepFRI for deep learning-based function prediction

  • ProFunc for comprehensive function prediction

• Data integration approaches:

  • Weighted prediction confidence scores

  • Consensus methods across multiple predictors

  • Network-based functional inference

The approach described by Konc et al. for uncharacterized proteins demonstrates how structure-based methods can reveal non-obvious functional relationships. Their success in identifying DNA binding activity in the Tm1631 protein by comparing predicted binding sites to a library of known structures illustrates the power of this approach . For IIV3-112R, similar methodology could identify functional properties not detectable through sequence analysis alone.

Successful function prediction for uncharacterized proteins often requires integration of multiple bioinformatic approaches, with experimental validation of the resulting hypotheses.

What are potential applications of IIV3-112R in recombinant protein research?

As an uncharacterized viral protein, IIV3-112R has several potential research applications that extend beyond understanding its native function:

1. Model system for structural biology methodologies:

• Novel structure determination approaches:

  • Test emerging crystallization techniques for challenging proteins

  • Develop optimized protocols for membrane-associated viral proteins

  • Evaluate new computational structure prediction algorithms

• Protein engineering platform:

  • Stability engineering through rational design

  • Expression optimization case studies

  • Solubility enhancement strategies

2. Immunological research applications:

• Antigen design and presentation studies:

  • Investigation of viral epitope processing

  • Development of diagnostic antibodies

  • Vaccine design methodology research

• Host-pathogen interaction models:

  • Study innate immune recognition of viral proteins

  • Analyze adaptive immune responses to novel viral antigens

  • Investigate immune evasion mechanisms

3. Biotechnology applications:

• Protein production system development:

  • Optimization of recombinant expression strategies

  • Tag configuration comparison studies

  • Purification protocol refinement

• Biosensor development:

  • Novel detection platforms for viral proteins

  • Environmental monitoring applications

  • Rapid diagnostic development methodologies

The methodological approaches used in recombinant vaccine development, such as those documented for RIV3, provide valuable insights into production and safety assessment of recombinant viral proteins . While RIV3 represents a different application context, the underlying methodologies for expression, purification, and characterization have transferable principles for IIV3-112R research.

For research applications requiring high-quality recombinant IIV3-112R, commercially available preparations with His-tag purification systems enable consistent starting material for experimental investigations .

How can CRISPR/Cas systems be used to investigate the role of IIV3-112R in viral replication?

CRISPR/Cas systems offer powerful tools for investigating viral protein functions like IIV3-112R through precise genome editing approaches:

1. Direct viral genome editing:

• Knockout studies:

  • Design guide RNAs targeting the IIV3-112R gene in the viral genome

  • Generate deletion mutants with precise boundaries

  • Create point mutations to disrupt specific domains while maintaining expression

• Reporter system integration:

  • Insert fluorescent or luminescent tags for tracking viral protein localization

  • Create fusion proteins for real-time monitoring of expression

  • Develop split reporter systems to detect protein-protein interactions

• Delivery considerations:

  • Package Cas9 and gRNAs in viral vectors or liposomes

  • Optimize timing of editing relative to viral infection

  • Implement inducible Cas9 systems for temporal control

2. Host cell engineering for interaction studies:

• Host factor identification:

  • Conduct genome-wide CRISPR screens to identify essential host factors

  • Create knockout cell lines of candidate interaction partners

  • Generate cell lines with tagged versions of potential host interactors

• Mechanistic investigations:

  • Engineer reporter cell lines responsive to viral protein activity

  • Create cellular biosensors for viral protein localization

  • Develop split protein complementation systems for interaction validation

3. Advanced CRISPR applications:

• Base editing approaches:

  • Use cytidine or adenine base editors for precise amino acid substitutions

  • Apply prime editing for complex sequence alterations

  • Implement multiplexed editing to study combinatorial effects

• Epigenetic modulation:

  • Employ CRISPRi to repress viral gene expression

  • Utilize CRISPRa to enhance expression for overexpression studies

  • Apply dCas9-based recruitment of chromatin modifiers to viral genomes

• Spatiotemporal control:

  • Implement optogenetic Cas systems for light-controlled editing

  • Utilize chemically inducible systems for temporal control

  • Apply tissue-specific promoters in in vivo models

Experimental design considerations:

When designing CRISPR experiments for IIV3-112R functional studies:

• Include comprehensive controls:

  • Non-targeting gRNAs

  • Editing of non-essential viral genes

  • Rescue experiments with complementing expression

• Validation strategies:

  • Confirm editing efficiency through sequencing

  • Verify protein expression changes through Western blotting

  • Assess phenotypic effects using multiple orthogonal assays

• Data analysis approaches:

  • Implement time-course analysis for temporal effects

  • Quantify viral replication through multiple methodologies

  • Apply systems biology approaches to understand network effects

The methodological framework used for studying uncharacterized proteins, as demonstrated with the Tm1631 protein , can be integrated with CRISPR approaches to generate and test hypotheses about IIV3-112R function through precise genetic manipulation.